Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can tackling stigma help end HIV? new study tests a dual approach

NCT ID NCT07708519

Disease control Sponsor: Makerere University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests a program called Ssinga Nze that combines training for clinic staff with one-on-one support for people living with or at risk of HIV. The goal is to reduce HIV-related stigma and help sex workers in Uganda stick with their HIV prevention or treatment. Researchers will measure whether the program improves PrEP adherence and viral suppression compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a combined clinic-level stigma reduction program (Total Facility Approach) and individual-level counseling (HIVE3)
What this could lead to
If effective, this approach could improve HIV prevention and treatment outcomes by reducing stigma in healthcare settings.
What could go wrong
This is a small pilot study, so results may not apply broadly. Stigma is complex and hard to change with short-term programs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older * Self-identification as a sex worker * Able and willing to provide written informed consent Exclusion Criteria: * unwilling to provide written informed consent for study procedures * have a physical or mental condition that prohibits informed consent and participation in study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV STIGMA

Contacts and locations

Locations

  • Infectious Diseases Institute, Makerere University

    Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.